Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
18.22
-0.03 (-0.16%)
Mar 19, 2026, 12:15 PM CST
SHE:002317 Market Cap
SHE:002317 has a market cap or net worth of 15.51 billion as of March 18, 2026. Its market cap has increased by 67.59% in one year.
Market Cap
15.51B
Enterprise Value
14.76B
Revenue
2.45B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.22
Market Cap Chart
Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 15.51B, an increase of 114.98%. That is a compound annual growth rate of 4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 15.51B | -3.85% |
| Dec 31, 2025 | 16.13B | 56.94% |
| Dec 31, 2024 | 10.28B | -24.46% |
| Dec 29, 2023 | 13.61B | -37.64% |
| Dec 30, 2022 | 21.82B | 126.34% |
| Dec 31, 2021 | 9.64B | 8.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Medicine | 16.25B |
| Nanjing King-Friend Biochemical Pharmaceutical | 16.24B |
| Guobang Pharma | 16.00B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 15.93B |
| Shenzhen Kangtai Biological Products | 15.88B |
| Hybio Pharmaceutical | 15.62B |
| Shenzhen Hepalink Pharmaceutical Group | 15.18B |
| Zhejiang Jiuzhou Pharmaceutical | 14.88B |